Quaker Chemical delivered adjusted EPS of $1.65 for Q4, falling 3.4% short of analyst expectations, though up from $1.33 a year earlier. Revenue rose to $468.48 million, surpassing forecasts by 0.7% and growing 5.5% year-over-year on higher specialty chemical shipments. Despite the quarterly EPS miss, Quaker Chemical shares have advanced approximately 27% since January, far outpacing the S&P 500’s 0.9% gain. Investors have rewarded consistent revenue growth and the company’s track record of estimate beats in two of the last four quarters. Analysts forecast Q1 EPS of $1.81 on $476.1 million in revenue and full-year EPS of $8.50 on $1.97 billion in revenue. The specialty chemicals sector sits in the bottom 24% of industry rankings, suggesting broader headwinds could influence future performance.